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Oxygen consumption for bioenergetic purposes has long been thought to be the prerogative of mitochondria. Nevertheless, mitochondrial gene
knockout (ρ0) cells that are defective in mitochondrial respiration require oxygen for growth and consume oxygen at the cell surface via trans-
plasma membrane electron transport (tPMET). This raises the possibility that cell surface oxygen consumption may support glycolytic energy
metabolism by reoxidising cytosolic NADH to facilitate continued glycolysis. In this paper we determined the extent of cell surface oxygen
consumption in a panel of 19 cancer cell lines. Non-mitochondrial (myxothiazol-resistant) oxygen consumption was demonstrated to consist of at
least two components, cell surface oxygen consumption (inhibited by extracellular NADH) and basal oxygen consumption (insensitive to both
myxothiazol and NADH). The extent of cell surface oxygen consumption varied considerably between parental cell lines from 1% to 80% of total
oxygen consumption rates. In addition, cell surface oxygen consumption was found to be associated with low levels of superoxide production and
to contribute significantly (up to 25%) to extracellular acidification in HL60ρ0 cells. In summary, cell surface oxygen consumption contributes
significantly to total cellular oxygen consumption, not only in ρ0 cells but also in mitochondrially competent tumour cell lines with glycolytic
metabolism.
© 2007 Elsevier B.V. All rights reserved.Keywords: Cell surface oxygen consumption; Aerobic glycolysis; ρ0 cells1. Introduction
Many aggressive and highly invasive cancers are character-
ized by increased reliance on glycolysis for energy production
even in the presence of oxygen and this is often referred to as
aerobic glycolysis or the Warburg effect [1–8]. From a
bioenergetic perspective glycolysis is relatively inefficient.
Nevertheless, it appears to confer a proliferative advantage on
many cells, particularly those in hypoxic micro-environments
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doi:10.1016/j.bbabio.2006.11.018with cells that obtain their energy through oxidative
phosphorylation. High glycolytic rates in rapidly proliferating
cells lead to a build up of reducing equivalents produced
during glycolysis and mitochondrial TCA cycle activity. In
addition to increased lactic acid production [4,10–13], highly
glycolytic cells also use trans-plasma membrane electron
transport (tPMET) to alleviate intracellular reductive stress
[14–19]. The extent to which tPMET is employed to support
aerobic glycolysis is difficult to assess in cells that use
mitochondrial electron transport for at least part of their energy
requirements. This issue has been addressed by employing the
mitochondrial gene-knockout ρ0 model of extreme aerobic
glycolysis [14,15,18,19].
We have shown previously that human leukemia HL60 ρ0
cells consume oxygen at the cell surface via tPMET [14]. The
cell-impermeable water-soluble tetrazolium dye, WST-1, is also
reduced by this tPMET system, but only in the presence of its
obligate intermediate electron acceptor, 1-methoxy-5-methyl
phenazinium methylsulphate (PMS) (Fig. 1). This excludes a
Fig. 1. Diagram of cell surface oxygen consumption andWST-1/PMS reduction.
Electrons travel from intracellular NADH to extracellular oxygen or PMS via an
NADH:oxidoreductase at the inner surface of the plasma membrane, the
ubiquinone cycle (ubiquinone: Q and semiubiquinone: QHU) and a cell surface
NADH:oxidoreductase. PMS radicals (PMSU) reduce WST-1 to a WST-1
radical (WST-1U) and then to WST-1H2 either by PMS radicals or superoxide
(O2
U−). Inhibition of cell surface oxygen consumption by NADH is postulated to
be caused by reverse electron transport of electrons from extracellular NADH
through the surface NADH: oxidoreductase to reduce ubiquinone to ubiquinol
(QH2).
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(NOX2) which, when activated by phorbol myristate acetate
(PMA), reduces WST-1 directly [20]. tPMET transports
electrons from intracellular NADH via an NADH: oxidoreduc-
tase at the inner surface of the plasma membrane to plasma
membrane ubiquinone which then reduces extracellular oxi-
dants via a cell surface NADH:oxidoreductase [14,21,22].
Here, we assess the extent of aerobic glycolysis in a panel of
19 human and mouse cancer cell lines by measuring their cell
surface oxygen consumption rates. Non-mitochondrial oxygen
consumption in ρ0 cells has been described by various authors
[15,23–27], however, the extent of this varied from very low to
undetectable [23–25] to around 10–30% of parental oxygen
consumption rates [15,26,28]. Significant cyanide-resistant
oxygen consumption in mitochondrially competent cell lines
has been reported for human lymphoblastic leukemia Molt-4
cells (60% of total oxygen consumption) [26] and CD34+
hemopoietic stem cells (HSC) (40% of total oxygen consump-
tion) [27]. Non-mitochondrial oxygen consumption in the latter
was suggested to be due to superoxide production by NOX2 and
NOX4 in the plasma membrane. We therefore investigated the
extent to which superoxide contributes to cell surface oxygen
consumption in HL60ρ0 cells.
Increased glycolytic rates have also been associated with
increased lactic acid production and extracellular acidification
[4,5,13,29], although it has been claimed that lactic acid
production by itself is not sufficient to explain the level of
acidification in glycolytic cancer cells [4,10,12]. In order to
maintain electroneutrality, increased electron transport across
the plasma membrane is also associated with proton extrusion.
We therefore investigated the contribution of cell surface oxygen
consumption to extracellular acidification in HL60ρ0 cells.2. Materials and methods
2.1. Cell lines and cell culture techniques
All mammalian cell lines were grown in RPMI-1640 medium supplemented
with 5% (v/v) fetal bovine serum, GlutaMAX-1 (2 mM), penicillin (100 U/mL),
streptomycin sulfate (100 μg/mL), uridine (50 μg/μL) and pyruvate (1 mM) to
densities of 0.5–1.0×106 cells/mL (exponential growth stage), at 37 °C in a
humidified incubator maintained at 5% CO2. The cell lines used were kind gifts
from the following people: the human myeloblastic leukemia cell line, HL60, from
Dr. Graeme Findley (University of Auckland, NZ); the human osteosarcoma cell
lines, 143B and 143Bρ0, from Dr. Michael P. Murphy (University of Otago,
Dunedin, New Zealand); the human cervical carcinoma cell lines, HeLa, from Dr.
Anthony Braithwaite (University of Otago, Dunedin, NZ); the non-adherent
human cervical carcinoma cell lines, HeLaS3 and HeLaS3ρ0, from Dr. Alfons
Lawen (Monash University, Melbourne, Australia); the murine mastocytoma cell
line, P815, from Dr. John. Marbrook (University of Auckland, NZ); the human
monocyte-like histiocytic lymphoma cell line, U937, from American Type Culture
Collection (Rockville, MD, USA); the murine myelomonocytic leukemia cell line,
WEHI213, the mature murine B cell lymphoma, A20, the murine T cell
lymphomas, EL4 and BW1100, the transformed murine monocyte/macrophage
cell line, J774, and the transformed murine dendritic cell line, D2SC/1, from Dr.
Franca Ronchese (Malaghan Institute, Wellington, NZ); the murine T cell
lymphoma, BW1100, and the human acute lymphoblastic leukaemia, Jurkat, from
Dr. Thomas Backström (Malaghan Institute, Wellington, NZ); the transformed
human macrophage cell line, RAW264.7, from Dr. Jacquie Harper (Malaghan
Institute, Wellington, NZ). HL60A (adherent) is a stable adherent cell line derived
from HL60 after 48 h incubation under alkaline conditions (pH 7.8–8.2), by clonal
dilutions in microplate wells. HL60ρ0 and HeLaρ0 were derived from their parental
strains by long-term culture (6–12 weeks) with 50 ng/mL filter-sterilized ethidium
bromide (EtBr) according to the protocol of King and Attardi [24] by A.S. Tan. The
ρ0 status of all ρ0 cell lines was verified by PCR to confirm the absence of mtDNA)
and by FCCP-insensitive WST-1/PMS reduction (A.S. Tan, unpublished results).
2.2. Materials
WST-1 (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tet-
razolium mono sodium salt) and PMS (1-methoxy-5methyl phenazinium
methylsulphate) were purchased from Dojindo Laboratories (Kumamoto,
Japan). Unless otherwise stated all other reagents were from Sigma Chemical
Company (St. Louis, MO, USA).
2.3. tPMET activity as measured by WST-1/PMS reduction
For inhibitor studies, WST-1/PMS reduction rates were measured in a
microplate format as described previously [17]. Briefly, exponentially growing
cells were centrifuged at 130×g for 5 min, washed and resuspended in Hanks
Balanced Salt Solution (HBSS) buffer. For each assay, 50 μL of a 2×106 cells/
mL cell suspension was pipetted into microplate wells containing 50 μL of the
inhibitor/buffer solution (10 μL of the 10× stock solution added to 40 μL of
HBSS buffer), resulting in a final concentration of 1×106 cells/mL. Dye
reductionwas initiated by adding 10μLof a 10× stock solution ofWST-1/PMS in
milliQ water (final concentrations of 500 μMWST-1 and 20 μM PMS). WST-1
reduction was measured in real time at 450 nM over 30–60 min in a BMG
FLUOstar OPTIMA plate reader.
2.4. Superoxide production
The extent of superoxide production was measured as WST-1 reduction in
the same manner as described above but in the absence of PMS [20].
2.5. Hydrogen peroxide production
The amount of hydrogen peroxide produced by cells was measured using the
Amplex Red glucose/glucose oxidase kit (Molecular Probes). The assay is based on
the oxidation of the Amplex Red reagent by hydrogen peroxide to form the fluore-
scent resorufin in the presence of horseradish peroxidase. For each experiment a
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H2O2 standard in the kit (0.88 M hydrogen peroxide, according to the manu-
facturer's instructions). Reaction mixture (50 μL of a suspension containing
50μL of 10mMAmplexRed reagent, 100μL of 10U/mLhorseradish peroxidase
and 4.85 mL reaction buffer) was added to 50 μL of either hydrogen peroxide
standards or cell supernatant. After incubation at room temperature for 10 min,
resorufin appearancewasmeasured at 560 nm in a FLUOstar Optima plate reader.
2.6. Oxygen consumption
Exponentially growing mammalian cultures were centrifuged at 130×g at
room temperature for 5 min (Megafuge 2R Heraeus) and resuspended in fresh
complete RPMI medium to a density of 2.5×107 cells/mL. Each experiment
measured oxygen consumption by 600 μl of resuspended cells in a 1 mL chamber,
surrounded by a water-filled chamber maintained at 37 °C. Oxygen consumption
was measured with a Clark-type dissolved oxygen electrode, coupled to a
Powerlab processor and a Macintosh computer using Powerlab software. The
oxygen concentration in fully oxygenated medium and cell cultures was taken to
be 200 nmol/mL (200 μM). Oxygen consumption rates were calculated in pmoles
per million cells per second. For example the oxygen consumption rate for a slope
of − 0.06 and 2×107 cells/mL was calculated as follows:
0:06 200ðnmol=mLÞ
60ðsÞ  20ð106 cellsÞ ¼ 0:01 nmol s
1106 cells1 or 10 pmol s1106 cells1
The effects of inhibitors on oxygen consumption were determined by
spiking stirred cells with the specified concentration of inhibitor after a stable
oxygen consumption had been achieved. Results, expressed as a percentage of
control, were obtained by dividing slopes in the presence of inhibitor by control
slopes within the same trace. All values were corrected for background readings
obtained from fresh medium without cells (background drift).
3. Results
3.1. Cell surface oxygen consumption in glycolytic cancer cell
lines
HL60ρ0 cells have previously been shown to consume
oxygen at the cell surface. In contrast, parental HL60 cells didTable 1
Comparison of WST-1/PMS reduction rates and O2 consumption rates
Cell line WST-1/PMS reduction Total O2 consumption Mitochondria
HL60 15.25±1.26 11.46±0.40 10.59±0.40 (
HeLa 50.85±1.61 26.86±0.85 25.25±0.84 (
143B 29.11±2.56 16.32±0.53 15.19±0.53 (
U937 17.48±0.99 11.00±0.83 9.90±0.53 (
Jurkat 14.79±0.81 11.89±0.50 8.90±0.50 (
WEHI 213 11.34±0.60 9.44±0.48 6.61±0.48 (
RAW264.7 21.03±1.37 8.89±0.23 5.76±0.10 (
A20 15.29±0.47 9.67±0.50 6.29±0.50 (
EL4 11.49±0.84 7.69±0.40 4.36±0.40 (
HeLaS3 19.51±0.90 8.42±0.32 4.54±0.32 (
P815 13.63±0.89 5.15±0.37 2.33±0.20 (
HL60adh 28.43±1.55 7.57±0.25 2.58±0.25 (
BW1100 40.83±1.80 8.11±0.35 1.95±0.35 (
D2SC/1 67.75±1.85 12.56±0.83 2.55±0.62 (
J774 34.10±1.24 6.18±0.33 0.62±0.33 (
HeLaρ0 89.72±3.91 12.50±0.50 0.01±0.50 (
143Bρ0 41.10±1.24 5.62±0.40 0.01±0.20 (
HL60ρ0 30.31±1.82 4.74±0.16 0.01±0.16 (
HeLaS3ρ0 38.34±1.39 5.64±0.21 0.03±0.21 (
Figures in brackets indicate percent of total O2 consumption. WST-1/PMS reduction v
O2 s
−1 106 cells−1. Results represents averages±SEM of three to six separate expernot exhibit significant levels of cell surface O2 consumption,
raising the question of physiological relevance [14]. Here, we
investigated whether cell surface oxygen consumption occurs in
cells with intact mitochondrial electron transport. We therefore
measured oxygen consumption in the absence and presence of
myxothiazol (inhibitor of mitochondrial oxygen consumption),
NADH, (inhibitor of cell surface oxygen consumption), and
both myxothiazol and NADH, using a panel of 19 human and
murine cancer cell lines available to us (Table 1). Interestingly,
non-mitochondrial oxygen consumption was shown to consist
of two distinct components, by sensitivity to extracellular
NADH, previously shown to extensively inhibit oxygen
consumption by HL60ρ0 cells [14]. When comparing non-
mitochondrial oxygen consumption rates in the presence and
absence of NADH in different cancer cell lines, we noted a small
NADH-insensitive component (between 3 and 11% of total
oxygen consumption rates) in the cell lines examined. We
suggest that the NADH-insensitive component of non-mito-
chondrial oxygen consumption is in fact a basal form of oxygen
consumption, not associated with tPMET or the support of
energy production.
The percentage cell surface oxygen consumption varied
between 1% and 90% of total oxygen consumption among the
different cell lines (Table 1). As expected, ρ0 cell lines (HL60ρ0,
HeLaρ0, HeLaS3ρ0 and 143Bρ0) showed no significant
mitochondrial oxygen consumption, whereas HL60, U937,
HeLa and 143B used mitochondrial oxygen consumption
exclusively. In all cases, ρ0 cells exhibited significantly lower
total oxygen consumption rates than their parental counterparts
(41% for HL60ρ0, 46% for HeLaρ0, 67% for HeLaS3ρ0: and
34% for 143Bρ0). Cell surface oxygen consumption in the
dendritic cell line, D2SC/1 and the monocyte/macrophage cell
line, J774, comprised a high percentage of total oxygen
consumption rates (71% and 80% respectively), whilst otherl O2 consumption Cell surface O2 consumption Basal O2 consumption
96%) 0.14±0.02 (1%) 0.43±0.02 (3%)
95%) 0.42±0.05 (1%) 1.19±0.04 (4%)
93%) 0.33±0.06 (2%) 0.81±0.02 (5%)
90%) 0.32±0.12 (3%) 0.79±0.07 (7%)
75%) 2.50±0.50 (21%) 0.49±0.03 (4%)
70%) 2.35±0.15 (25%) 0.48±0.02 (5%)
66%) 2.68±0.21 (30%) 0.37±0.01 (4%)
65%) 2.91±0.17 (30%) 0.47±0.02 (5%)
57%) 2.87±0.16 (37%) 0.46±0.02 (6%)
54%) 3.27±0.13 (39%) 0.61±0.02 (7%)
35%) 2.86±0.38 (55%) 0.53±0.04 (10%)
34%) 4.44±0.16 (58%) 0.55±0.02 (7%)
24%) 5.43±0.26 (67%) 0.73±0.03 (9%)
20%) 8.91±0.65 (71%) 1.10±0.08 (9%)
10%) 4.95±0.30 (80%) 0.61±0.03 (10%)
2%) 10.70±1.25 (87%) 1.35±0.04 (11%)
1%) 4.91±0.40 (88%) 0.72±0.04 (11%)
1%) 4.29±0.16 (90%) 0.44±0.03 (9%)
1%) 4.83±0.21 (90%) 0.68±0.02 (9%)
alues are in milliA450 min−1 105 cells−1 and O2 consumption rates are in pmoles
iments.
Fig. 3. Superoxide (O2
U−) production (A) and hydrogen peroxide (H2O2)
production (B) by HL60 and HL60ρ0 cells in the presence and absence of
PMS. Superoxide production was measured as WST-1 reduction at 450 nm
(milliA450 min−1 105 cells−1) in the presence or absence of PMS (20 μM) and
H2O2 reduction measured as resorufin production at 560 nm (milliA560 min
−1
105 cells−1) in the presence and absence of PMS (20 μM). Results are
averages±SEM of three separate experiments and are presented as percent
superoxide or hydrogen peroxide production in the absence of PMS compared
to that in the presence of PMS (C). Diagram of generation of PMSU, O2U−,
H2O2 and WST-1H2 by electrons from tPMET. Oxygen and PMS compete for
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consumption. If the assumption is made that the purpose of cell
surface oxygen consumption is to support glycolytic energy
production, then it follows that 90% of the bioenergetic oxygen
consumption in J774 cells and all of the bioenergetic oxygen
consumption in ρ0 cells is cell surface associated. These results
challenge the current respiratory paradigm that all bioenergetic
oxygen consumption in mammalian cells is mitochondrial.
There was no clear relationship between total cellular oxygen
consumption and WST-1/PMS reduction (Table 1). Of the
mitochondrially competent cells, the murine dendritic cell line,
D2SC/1 exhibited the highest WST-1/PMS reduction but the
third highest rates of total oxygen consumption. In contrast, HeLa
cells had high rates of both WST-1/PMS reduction and total
oxygen consumption. Because cell surface oxygen consumption
uses the same tPMET system as WST-1/PMS reduction [14], we
compared the rates of WST-1/PMS reduction and cell surface
oxygen consumption (Fig. 2A). When all cell lines were included
in the analysis, the correlation was poor (R2=0.5898) but,
interestingly, improved significantly (R2=0.98) when cell lines
that exclusively employ a mitochondrial energy metabolism
(open circles in Fig. 2A) were excluded from analysis. This is an
empirical observation: the reasons why some cancer cell types
that are obviously capable of tPMET (as evidenced by their
ability to reduce WST-1 in the presence of PMS) do not use that
same system for cell surface oxygen consumption is not readily
explained. It may relate to the artificial nature of the dye reduction
system or to the consequences of switching from a purely
mitochondrial energy metabolism to a combined mitochondrial/Fig. 2. (A) Relationship between WST-1/PMS reduction and cell surface oxygen
consumption in different cell lines. Cell surface oxygen consumption was
determined as the NADH-sensitive component of total oxygen consumption. The
R2 value in graph (A) empirically excludes those cell lines with no significant cell
surface oxygen consumption (HL60, HeLa, 143B, U937). Oxygen consumption
rates are in pmoles O2 s
−1106 cells−1, WST-1/PMS reduction values are in
milliA450 min−1 105 cells−1. Results represent averages±SEM of three to six
separate experiments. (B). Relationship between FCCP-inhibited WST-1/PMS
reduction and cell surface oxygen consumption. The effect of FCCP (2 μM) on
WST-1/PMS reduction was determined and compared with cell surface oxygen
consumption. Percentage surface oxygen consumption refers to the percentage of
total oxygen consumption and percentage FCCP inhibition refers to inhibition of
WST-1/PMS reduction in the presence of FCCP, compared with that in the absence
of FCCP. Results are the average of at least three different experiments. The
following cell lineswere tested;HeLa (50%),HL60 (49%),A20 (26%), EL4 (25%),
HeLaS3 (30%), BW1100 (9%), HL60ρ0 (3%), HeLaρ0 (2%), HeLaS3ρ0 (3%).
electrons from tPMET. Superoxide contributed ∼3% to WST-1/PMS reduction
(A) and PMS radicals (PMSU) contributed ∼97%. H2O2 is produced by
dismutation of superoxide with ∼70% coming directly via tPMET and ∼30%
originating from PMS radicals (B). This suggests that PMS-generated
superoxide contributed ∼1% to WST-1/PMS reduction (30% of 3%), and
tPMET-generated superoxide by itself was responsible for ∼2% of WST-1/
PMS reduction.glycolytic metabolism (supported by tPMET), resulting in
activation in some but not all cancer cell types.
Previous work by our group has shown a strong inhibitory
effect of the respiratory uncoupler, FCCP, on WST-1/PMS
reduction by HL60 cells, whilst dye reduction by HL60ρ0 cells
remains unaffected [14]. Inhibition of dye reduction by FCCP in
parental HL60 cells is consistent with increased mitochondrial
electron transport, causing lowering of intracellular NADH
levels, as shown by others. We found a strong correlation
(R2 =0.9688) between the percentage inhibition of WST-1/PMS
reduction by FCCP and the percentage of cell surface oxygen
consumption (Fig. 2B). These results indicate that inhibition of
WST-1/PMS reduction by FCCP may be a good measure of the
extent of glycolytic metabolism.
3.2. Contribution of superoxide to cell surface oxygen
consumption
Because non-mitochondrial oxygen consumption in human
hemopoietic stem cells was reported to be due to superoxide
production by NOX 2 and NOX 4 [27], we next examined
Fig. 4. Effect of PMS (20 μM), followed by WST-1 (500 μM) on oxygen
consumption rates by (A) HL60ρ0 cells and (B) on non-mitochondrial oxygen
consumption by HL60 cells in the presence of myxo (myxothiazol: 1 μg/mL).
Arrows indicate the points at which the various compounds were added. Results
are representative of two separate experiments.
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superoxide component. We used HL60 and HL60ρ0 cells to
model the two extremes of oxygen consumption as HL60 cells
consume oxygen largely in their mitochondria and HL60ρ0
cells use oxygen at the cell surface. Oxygen consumption, using
a Clark dissolved oxygen electrode, does not distinguish
between the possible end products, water and superoxide/
hydrogen peroxide. One way to examine the role of superoxide
in dye reduction is to utilize the ability of superoxide to reduce
WST-1 directly at the cell surface [20]. We measured WST-1
reduction rates in HL60 and HL60ρ0 cells in the presence and
absence of PMS (Fig. 3A). Low levels of superoxide were
detected in the absence of PMS (2–3% of the dye reduction
measured in the presence of PMS). However, the contribution of
superoxide to WST-1 reduction in the presence of PMS is
complicated because electrons from tPMET will produce PMS
radicals with both superoxide and PMS radicals existing in
equilibrium, and being able to reduce WST-1 (Fig. 3C). In
addition, dismutation of superoxide, accelerated by the cell-
impermeable superoxide scavenger, superoxide dismutase
(SOD), leads to the formation of hydrogen peroxide, resulting
in lower superoxide measurements than actually produced. We
therefore used Amplex Red to determine the extent of hydrogen
peroxide formation in the absence and presence of PMS (Fig.
3B). HL60ρ0 cells were found to produce 3 times as much
superoxide (as measured by WST-1 reduction) and 2.5 times as
much hydrogen peroxide (as measured by resorufin production)
as HL60 cells. Interestingly, the addition of PMS increased
resorufin production by 30% (Fig. 3B) and WST-1 reduction
30- to 50-fold (Fig. 3A,C). SOD extensively inhibited WST-1
reduction and WST-1/PMS reduction by about 70% (Table 2),
indicating superoxide involvement in both reductive processes.
Because WST-1/PMS reduction increases several fold in the
absence of oxygen [14], involvement of superoxide in this
pathway is clearly indirect. Mitochondrial oxygen consumption,
as expected, was unaffected by SOD, while cell surface oxygen
consumption by HL60ρ0 cells was inhibited by 27%, possibly
partially masked by superoxide dismutation and oxygen
generation via SOD and catalase. Interestingly, 10 μM
diphenylene iodonium (DPI), a potent NOX2 inhibitor at this
concentration [30], did not affect superoxide production in
either cell type. WST-1/PMS reduction and cell surface oxygen
consumption were inhibited to the same extent by DPI in
HL60ρ0 cells (37% and 42% respectively), whereas mitochon-
drial oxygen consumption remained unaffected.Table 2
Percentage inhibition of dye reduction and oxygen consumption
% Inhibition 25 μM SOD 10 μM DPI 2 mM Zn2+
HL60 HL60ρ0 HL60 HL60ρ0 HL60 HL60ρ0
O2 consumption 2±3 27±8 6±3 37±4 2±4 27±9
WST-1/PMS 73±2 71±2 39±4 42±5 52±6 48±3
WST-1 97±6 96±5 5±3 3±4 ND ND
O2 consumption was measured in pmoles O2 s
−1 106 cells−1, WST-1 and WST-
1/PMS reduction were measured in milliA450 min−1 105 cells−1. Results are
averages±SEM from at least three separate experiments.We have shown previously that PMS and oxygen compete
for electrons from the same tPMET pathway and that WST-1/
PMS reduction is increased by up to 4-fold under anaerobic
conditions [14]. Surprisingly, PMS caused a dramatic increase
in cell surface oxygen consumption in both HL60ρ0 and HL60
cells (Fig. 4) and this has also been observed in other cell types
in our laboratory (results not shown). This increased cell surface
oxygen consumption was inhibited in a concentration-depen-
dent manner by adding WST-1 (Fig. 4B). A similar inhibitory
effect of WST-1 was observed in HL60 cells in the presence
(Fig. 4B) and absence (results not shown) of myxothiazol.
These results suggest that PMS picks up electrons from tPMET,
producing PMS radicals that then efficiently reduce oxygen to
superoxide, contributing to oxygen consumption. Nevertheless,
as WST-1 in the presence of PMS is reduced in the absence of
oxygen, PMS radicals must also efficiently reduce WST-1. We
propose that WST-1, when added to this mixture, directly
competes with oxygen for electrons from the PMS radicals,
counteracting the PMS-induced increase in oxygen consump-
tion at the cell surface of both HL60ρ0 and HL60 cells (Fig.
3C).
3.3. tPMET activity contributes to acidification of the medium
We next investigated the contribution of tPMET to
extracellular acidification. In order to address this issue, it is
important to distinguish between proton production by LDH
and by tPMET. Purely glycolytic ρ0 cells would be expected to
maximally use LDH to reoxidise NADH and consequently to
produce protons stoichiometrically. If cell surface oxygen
consumption contributes to medium acidification, then inhibit-
ing this process should decrease acidification rates. Changes in
acidification rates were recorded with a pH micro-electrode
coupled to a Clark oxygen electrode. As expected, HL60ρ0
cells acidified the medium much more rapidly than HL60 cells
(Fig. 5A and B). Addition of NADH to HL60ρ0 cells
eliminated cell surface oxygen consumption, concomitant
with a decrease in acidification rate from 0.16 to 0.12 pH
units min−1 107 cells−1 or by 25% (Fig. 5C), and from 0.20 to
0.165 pH units min−1 107 cells−1, or by 18% (Fig. 5D). In
contrast, the rate of acidification by HL60 cells increased after
Fig. 5. Comparison of the effects of myxothiazol and NADH on oxygen
consumption and acid formation by HL60 cells and HL60ρ0 cells. HL60 cells
(A) and HL60ρ0 cells (B) were simultaneously monitored for oxygen
consumption (grey traces) and pH (black traces) in a modified Clark type
oxygen electrode. (C) Effect of NADH (1 mM) on oxygen consumption (grey
trace) and pH changes (black trace) in HL60ρ0 cells. (D) Effects of NADH
(1 mM) and myxo (myxothiazol 1 μg/mL) on pH changes in HL60 and HL60ρ0
cells. Results are representative of three separate experiments.
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107 cells− 1). These results demonstrate that tPMET is
associated with proton extrusion and extracellular acidification,
although the mechanism is unclear. Bivalent cations, such as
Zn2+, have been shown to extensively inhibit voltage-gated
proton channels, such as those associated with NOX2 activity in
phagocytes [31,32]. In support of a role for voltage-gated proton
channels in tPMET, cell surface oxygen consumption in
HL60ρ0 cells and WST-1/PMS activity in both HL60 and
HL60ρ0 cells were found to be sensitive to Zn2+, whereas
mitochondrial oxygen consumption in HL60 cells remained
unaffected (Table 2).
4. Discussion
Recent studies have shown a trend towards increased
aggressiveness in cancers that are more glycolytic compared
with their less glycolytic counterparts [1,3,4,8,33]. However,
the extent of aerobic glycolysis in normal tissues and in
tumours is controversial. Different methods have been used to
distinguish between glycolysis and mitochondrial energy
metabolism, making it difficult to compare results between
research groups. Guppy and coworkers suggest that mitochon-
drial energy metabolism should be determined by oxygen
consumption and glycolysis by lactic acid production [34–37].
However, as is apparent from the results presented in thispaper, this would only apply to mitochondrial oxygen
consumption rates and not to total oxygen consumption
rates. Here, we show that non-mitochondrial (myxothiazol-
resistant) oxygen consumption consists of cell surface oxygen
consumption (inhibited by NADH) and basal oxygen
consumption (unaffected by myxothiazol or NADH). We
hypothesise that cell surface oxygen consumption rates
indicate the extent of aerobic glycolysis and that these rates
vary extensively between cell types (from 1% to 80% of total
oxygen consumption rates in mitochondrially competent cell
lines). This may, at least in part, explain the wide range of
non-mitochondrial oxygen consumption rates reported in the
literature, from very low or undetectable levels [23–25], to
40% of total oxygen consumption rates [15,26–28].
We further show that the extent of cell surface oxygen
consumption is strongly correlated with FCCP-inhibitableWST-
1/PMS reduction. This may represent a simple and reliable assay
for measuring the extent of aerobic glycolysis, additional to
LDH activity. Glycolytic cancers are resistant to drugs that target
mitochondrially competent cells, and a simple assay that
determines the extent of glycolytic metabolism in cancer cells
may influence treatment options in a clinical setting.
Oxygen consumption at the cell surface raises questions
about the molecular nature of this oxygen consuming system. A
recent paper by Piccolo et al. described the presence of two
NOX isoforms, NOX2 and NOX4, on CD34+ human
hemopoietic stem cells. These NADPH oxidases were con-
stitutively expressed and could not be activated in the usual
manner by PMA [27]. Cyanide-resistant oxygen consumption
of up to 40% of total oxygen consumption was attributed to
superoxide production by these NOX isoforms. Oxygen
consumption levels in the presence of KCN were reported to
be 0.83 pmoles O2 s
−1 106 cells−1. These rates are extremely
low but compare well with the basal oxygen consumption rates
presented in Table 1, ranging from 0.37 to 1.35 pmoles O2 s
−1
106 cells−1. This raises the intriguing possibility of NOX
isoforms being present on the cell membrane of many cell lines
and actively producing low levels of superoxide possibly for
cell signalling purposes. This seems particularly plausible for
HL60 as this is a myeloblastic leukemia cell line which, upon
differentiation with dimethylsulfoxide, all–trans-retinoic acid or
arsenic trioxide and stimulation with PMA, produces a
significant respiratory burst, mediated by NOX2 [38] (and
Herst et al., manuscript in preparation). It is conceivable that
undifferentiated HL60 cells constitutively produce low levels of
superoxide through NOX2. By using WST-1 reduction in the
absence of PMS, we show that both HL60 and HL60ρ0 cells
produced small amounts of superoxide that was not inhibited by
10 μM DPI. In contrast, NOX2 activity is strongly inhibited by
DPI at concentrations as low as 1 μM [39]. These results argue
strongly against a role for NOX2 in superoxide production in
HL60 and HL60ρ0 cells. In HL60ρ0 cells, superoxide could be
produced as a result of one-electron leakage from a cell surface
oxidase during cell surface oxygen consumption. However,
HL60 cells do not consume oxygen at the cell surface at levels
detectable by a Clark-type oxygen electrode. This suggests that
electron leakage may occur at other sites on the surface oxidase
176 P.M. Herst, M.V. Berridge / Biochimica et Biophysica Acta 1767 (2007) 170–177or at other sites in the tPMET system (e.g. CoQ10) or that
superoxide production occurs via another unrelated tPMET
pathway.
The ability of highly glycolytic cells to acidify the medium
has been observed in many studies [2,4,7,10–13,23,40,41]. In
support of these studies, we found that glycolytic HL60ρ0
cells acidified the medium much more rapidly than HL60
cells (Fig. 5). As expected, blocking mitochondrial oxygen
consumption in HL60 cells with myxothiazol led to an
approximately two-fold increase in acidification rate. Abol-
ishing mitochondrial electron transport is expected to result in
an increase in glycolytic rate with a concomitant increase in
LDH activity to re-oxidise NADH. When cell surface oxygen
consumption in HL60ρ0 cells was blocked by extracellular
NADH, the acidification rate decreased. This suggests that, in
addition to lactic acid, cell surface oxygen consumption may
account for up to 25% of the total acidification rate exhibited
by HL60ρ0 cells. These results confirm previous reports that
acidification by glycolytic tumour cells is only partially due
to increased lactic acid production [4,10,12]. Although there
are a number of proton transport mechanisms associated with
the plasma membrane, such as the N+/H+ antiporter, the H+/
HCO3
− symporter and the H+-ATPase, efficient H+ transport
also occurs via voltage-gated H+ channels which do not use
energy and are two orders of magnitude faster than other
proton transporters [42]. Bivalent cations, especially Zn2+,
extensively inhibit voltage-gated proton channels at levels as
low as 10 μM in patch-clamp experiments [42–44], and at
100–300 μM Zn2+ in whole cell cultures [45–47]. Zn2+
inhibition of WST-1/PMS reduction (IC50:2 mM) and cell
surface oxygen consumption (IC50:4 mM) required much
higher Zn2+ concentrations, possibly due to a difference in
accessibility of Zn2+ binding sites. These results do not
distinguish between direct inhibition by Zn2+ binding to the
active site of the surface NADH: oxidoreductase of the
tPMET system, or indirect inhibition by Zn2+ binding to
associated voltage-gated H+ channels. In the latter case,
abolishing H+ extrusion would inhibit tPMET by compromis-
ing electroneutrality during electron transport across the cell
membrane. Although these results suggest involvement of
voltage-gated H+ channels in the acidification associated with
tPMET, a role for other proton transport mechanisms cannot
be excluded.
In summary, we have shown here that the extent of cell
surface oxygen consumption varies extensively between
different cancer cell lines and that this is directly related to
the percentage FCCP-inhibited WST-1/PMS reduction. We
propose that the best method of determining the extent of
mitochondrial energy production is to measure myxothiazol-
inhibited oxygen consumption and not total oxygen consump-
tion as previously suggested [37]. We show that the extent of
aerobic glycolysis may be related to cell surface oxygen
consumption or the percentage FCCP-inhibited WST-1/PMS
reduction. We also showed that HL60 and HL60ρ0 cells
produced low levels of superoxide, which contributed only
marginally to cell surface oxygen consumption and that
superoxide production was unlikely to be mediated by any ofthe NOX isoforms. Cell surface oxygen consumption was
further demonstrated to contribute up to 25% to extracellular
acidification in HL60ρ0 cells, possibly via voltage-gated proton
channels.
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